Track the HilleVax, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Technology sector, HilleVax, Inc. has published 45 insider filings. Market capitalisation: €1,096.4bn. The latest transaction was reported on 19 September 2025 (U). Among the most active insiders: Kohli Aditya. All data is openly available.
45
Insider Decl.
n/a
Thresholds
€138,042
2 ops.
Buy Volume
€2m
18 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HilleVax, Inc. Strong Buy (bullish), based on 42 analysts. Average price target: US$1,491.95.
32Σ signal
Buys €138,042€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,841 of 29,062 companies
71.3
score / 100
Value
64
Quality
79
FCF yld1.2%
Earn yld6.4%
EV/EBITDA8.1x
ROE67%
Gross mgn40%
Net mgn23%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.